Bacterial fimbriae activate human peripheral blood monocytes utilizing TLR2, CD14 and CD11a/CD18 as cellular receptors

Bacterial fimbriae are associated with a specific adherence factor, adhesin, in their microbial etiology. Porphyromonas gingivalis, as an anaerobic Gram‐negative periodontopathogenic organism, is known to possess fimbriae on its cell surfaces. In this study, we demonstrated that P. gingivalis fimbriae and an active synthetic peptide composed of residues 69 – 73 of thefimbrial subunit protein, ALTTE, induced IL‐6 mRNA expression and cytokine production, p38 mitogen‐activated protein (MAP) kinase phosphorylation, and NF‐κB activation in human peripheral blood monocytes. P. gingivalis fimbriae and ALTTE also induced IL‐6 production via human Toll‐like receptor (TLR) 2, CD14, and CD11a/CD18 (LFA‐1) molecules on human monocytes. These results suggest that P. gingivalis fimbriae and these degraded peptides may play an important role in the inflamed gingival and periodontal tissues seen in the development and progression of periodontal diseases.

[1]  A. Bøyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. , 1968 .

[2]  J. van Houte,et al.  Selective Bacterial Adherence to Oral Epithelial Surfaces and Its Role as an Ecological Determinant , 1971, Infection and immunity.

[3]  W. Gilbert,et al.  Sequencing end-labeled DNA with base-specific chemical cleavages. , 1980, Methods in enzymology.

[4]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[5]  S. Kusumoto,et al.  Total Synthesis of Lipid A, Active Principle of Bacterial Endotoxin , 1984 .

[6]  R. Genco,et al.  Microbial Pathogenicity Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in Human Periodontal Disease: Virulence Factors in Colonization, Survival, and Tissue Destruction , 1984, Journal of dental research.

[7]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[8]  J. Ebersole,et al.  Preparation and characterization of human gingival cells. , 1987, Journal of periodontal research.

[9]  T. Hirano,et al.  Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritis , 1988, European journal of immunology.

[10]  A Muraguchi,et al.  The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells , 1988, The Journal of experimental medicine.

[11]  R. Nordan,et al.  B cell growth and differentiation activity of interleukin‐hp1 and related murine plasmacytoma growth factors. synergy with interleukin 1 , 1988, European journal of immunology.

[12]  F. R. Saglie,et al.  In situ correlative immuno-identification of mononuclear infiltrates and invasive bacteria in diseased gingiva. , 1988, Journal of periodontology.

[13]  Y. Ohmori,et al.  Bacteroides gingivalis fimbriae stimulate production of thymocyte-activating factor by human gingival fibroblasts , 1988, Infection and immunity.

[14]  A. Muraguchi,et al.  Involvement of IL-6 in mesangial proliferative glomerulonephritis. , 1989, Journal of immunology.

[15]  N. Hogg.  The leukocyte integrins. , 1989, Immunology today.

[16]  T. Ogawa,et al.  Analysis of human IgG and IgA subclass antibody-secreting cells from localized chronic inflammatory tissue. , 1989, Journal of immunology.

[17]  P. Sassone-Corsi,et al.  A multiple cytokine- and second messenger-responsive element in the enhancer of the human interleukin-6 gene: similarities with c-fos gene regulation , 1989, Molecular and cellular biology.

[18]  S. Wright,et al.  CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide , 1989, The Journal of experimental medicine.

[19]  Ernest S. Kawasaki,et al.  Detection of Gene Expression , 1989 .

[20]  D. P. Murphy,et al.  Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[21]  P. Baeuerle,et al.  Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B , 1990, Molecular and cellular biology.

[22]  S. Akira,et al.  Constitutive and interleukin-1 (IL-1)-inducible factors interact with the IL-1-responsive element in the IL-6 gene , 1990, Molecular and cellular biology.

[23]  R. Ulevitch,et al.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.

[24]  T. Ogawa,et al.  Immunobiological activities of synthetic peptide segments of fimbrial protein from Porphyromonas gingivalis. , 1991, Biochemical and biophysical research communications.

[25]  T. Ogawa,et al.  Distribution and immunochemical specificities of fimbriae of Porphyromonas gingivalis and related bacterial species. , 1991, Oral microbiology and immunology.

[26]  M. Krieger,et al.  Recognition and plasma clearance of endotoxin by scavenger receptors , 1991, Nature.

[27]  C. Svanborg,et al.  Adhesion-dependent activation of mucosal interleukin-6 production , 1991, Infection and immunity.

[28]  T. Ogawa,et al.  Occurrence of antigen-specific B cells following oral or parenteral immunization with Porphyromonas gingivalis fimbriae. , 1992, International immunology.

[29]  C. Svanborg,et al.  Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro , 1992, Infection and immunity.

[30]  A. DeFranco,et al.  Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages. , 1992, The Journal of biological chemistry.

[31]  The leukocyte surface antigens CD11b and CD18 mediate the oxidative burst activation of human peritoneal macrophages induced by type 1 fimbriated Escherichia coli , 1993, Journal of leukocyte biology.

[32]  A. Allison,et al.  Some antioxidants inhibit, in a co-ordinate fashion, the production of tumor necrosis factor-α, IL-β, and IL-6 by human peripheral blood mononuclear cells , 1994 .

[33]  Antitumor synthetic lipid A analog DT-5461a upregulates cytokine expression in a murine macrophage cell line through LPS pathway. , 1994, Cellular immunology.

[34]  Y. Murakami,et al.  Porphyromonas gingivalis fimbriae induce a 68-kilodalton phosphorylated protein in macrophages , 1994, Infection and immunity.

[35]  A. Deisseroth,et al.  Interaction of nuclear proteins with an AP‐1/CRE‐like promoter sequence in the human TNF‐α gene , 1994 .

[36]  T. Ogawa,et al.  Humoral and cellular immune responses to the fimbriae of Porphyromonas gingivalis and their synthetic peptides. , 1994, Journal of medical microbiology.

[37]  L Bibbs,et al.  A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. , 1994, Science.

[38]  T. Ogawa,et al.  A peptide, ALTTE, within the fimbrial subunit protein from Porphyromonas gingivalis, induces production of interleukin 6, gene expression and protein phosphorylation in human peripheral blood mononuclear cells. , 1995, FEMS immunology and medical microbiology.

[39]  F. Mooi,et al.  Binding of FimD on Bordetella pertussis to very late antigen-5 on monocytes activates complement receptor type 3 via protein tyrosine kinases. , 1995, Journal of immunology.

[40]  Differential induction of IL-1 beta and IL-6 production by the nontoxic lipid A from Porphyromonas gingivalis in comparison with synthetic Escherichia coli lipid A in human peripheral blood mononuclear cells. , 1996, FEMS immunology and medical microbiology.

[41]  T. Ogawa,et al.  Hyporesponsiveness of inflamed human gingival fibroblasts from patients with chronic periodontal diseases against cell surface components of Porphyromonas gingivalis. , 1997, FEMS immunology and medical microbiology.

[42]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.

[43]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[44]  R. Medzhitov,et al.  The Toll-receptor family and control of innate immunity. , 1999, Current opinion in immunology.

[45]  S. Akira,et al.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.

[46]  S. Akira,et al.  Unresponsiveness of MyD88-deficient mice to endotoxin. , 1999, Immunity.

[47]  A. Aderem,et al.  The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens , 1999, Nature.

[48]  S. Akira,et al.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.

[49]  P. Godowski,et al.  Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. , 1999, Science.

[50]  R. Munford,et al.  Lipopolysaccharide-Binding Protein and Phospholipid Transfer Protein Release Lipopolysaccharides from Gram-Negative Bacterial Membranes , 2000, Infection and Immunity.

[51]  T. Kirikae,et al.  Regulatory roles for CD14 and phosphatidylinositol in the signaling via toll-like receptor 4-MD-2. , 2000, Biochemical and biophysical research communications.

[52]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[53]  T. Hartung,et al.  Induction of Cross-Tolerance by Lipopolysaccharide and Highly Purified Lipoteichoic Acid Via Different Toll-Like Receptors Independent of Paracrine Mediators1 , 2001, The Journal of Immunology.

[54]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[55]  S. Akira,et al.  CD11b/CD18 Acts in Concert with CD14 and Toll-Like Receptor (TLR) 4 to Elicit Full Lipopolysaccharide and Taxol-Inducible Gene Expression1 2 3 , 2001, The Journal of Immunology.

[56]  S. Akira,et al.  The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 , 2001, Nature.

[57]  S. Akira,et al.  Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway , 2002, Nature Immunology.